C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline PNR Q1 2026 Earnings Pentair Beats EPS Estimates Stock Rises SOWG Q3 2025 Earnings Massive EPS Miss Highlights Operational Headwinds Lexeo Therapeutics Q1 2026 Earnings EPS Beat on Lower Operating Costs GLPG Q1 2026 Earnings Significant EPS Beat Driven by Cost Control and Operational Efficiency Globant Q1 2026 Earnings EPS Slightly Below Estimates Stock Slips